American Diabetes Association Annual Meeting, 1998. Treatment of type 2 diabetes.
Bloomgarden
Z T
ZT
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism
D007004:Hypoglycemic Agents; D009687:Nuclear Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D013844:Thiazoles; D045162:Thiazolidinediones; D014157:Transcription Factors; D008687:Metformin; C089946:2,4-thiazolidinedione